novidades científicas Novo

16:13 European Cardiovascular Disease Statistics 2017
10:47 CETP inhibitor meets primary endpoint in CV outcome study
9:54 Arrhythmias and devices
14:31 Clinically significant bleeding with low-dose rivaroxaban versus aspirin, in addition to P2Y12 inhibition, in acute coronary syndromes (GEMINI-ACS-1): a double-blind, multicentre, randomised trial
14:18 Rivaroxaban or Aspirin for Extended Treatment of Venous Thromboembolism

Cessação Tabágica

16 Outubro 2014

Ana Rita Oliveira
USF Santiago

PARTE 1

PARTE 2

DVT and Pulmonary Embolism. Update 2014

16 Outubro 2014
0

Bleeding the biggest concern in the cath lab and CCU - Amadeu Betriu

16 Outubro 2014
0

-->